2024 Virtual Introductory Training Course
Pharmacokinetics & Pharmacodynamics 
of Protein Therapeutics
- Concepts and Hands-on Exercises -

Course Directors: 
Bernd Meibohm, University of Tennessee, Memphis, USA
Johan Gabrielsson, MedDoor AB, Gothenburg, Sweden

The 5-day course will introduce participants to basic principles in the pharmacokinetic and pharmacodynamic evaluation of novel protein therapeutics and provide opportunities for hands-on PK/PD analysis exercises. Topics include target-mediated drug disposition, interspecies scaling, first-in human dose selection, model-informed drug development, covariate and disease effects, bispecifics, and immunogenicity. 

Date: April 15-19, 2024    
Time: Daily 9:00 am - 2:00 pm US Central Daylight Saving Time

Last updated: January 21, 2024
Participants of the 9th 'PKPD of Protein Therapeutics' pharmacometric training course 2019
Hand-on exercises will be performed in demonstrations and as work assignments. There is no prior modeling experience required.

The course has been held annually since 2011 in a 5-day version and since 2016 also in a 3-day version in North America, Europe and Asia. It has been attended by several hundred scientists from large and small pharma (including companies such as Abbvie, Amgen, AstraZeneca/MedImmune, Bayer, Biogen-Idec, Bristol-Myers, Boehringer, Janssen, EMD Serono, Genentech, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron, Sanofi, and Roche), academic institutions, and major regulatory agencies.
Testimonials from previous participants:

"Good course all around. Lots to digest and good ammunition to take back to project teams and management!"

"This course was really a good opportunity to learn PK-PD of proteins. I will definitely apply the concepts in my research and encourage my peers to attend the course."

"I was very impressed with the course. I was wishing I had attended long ago before I started any work with biologics. My projects would have gone a lot smoother had I had this knowledge earlier. Almost wished it was longer, though that would be difficult, because there was so much to learn!"

"Best course ever!"